Maekawa, Emi
Dahanukar, Anupama A.
Funding for this research was provided by:
National Institutes of Health (R21AI140065)
Article History
Received: 18 September 2024
Accepted: 12 December 2024
First Online: 30 December 2024
Change Date: 18 July 2025
Change Type: Update
Change Details: This article has been updated to amend the license information.
Declarations
:
: A. Dahanukar’s spouse is a Founder and President of two startups, Sensorygen Inc. and Remote Epigenetics Inc., and is listed as inventor on multiple patents filed by UC Riverside. All the remaining authors declare no conflict of interest.